Business & Economics

SutroVax Closes U.S. $ 110 million Series D financing to Advance Novel Conjugate Vaccine...

SutroVax, a next-generation vaccine company, has closed a $110 million Series D preferred stock financing, co-led by new investors...

Silverback Raises U.S. $78.5 Million to Advance SBT6050 into the Clinic for HER2-expressing Solid...

Seattle-based Silverback Therapeutics™, a biopharmaceutical company pioneering a new class of immune-modulating ImmunoTAC™ drug conjugates targeting previously inaccessible disease...

Growing Number of Major Medical Meetings Cancelled – AACR and Others Postponed

The novel coronavirus, also known as COVID19, is prompting major medical societies and healthcare organizations to cancel conferences and...
MabPlex has started operations of two cell culture production lines of GE brand 2,000-liter single-use bioreactors. Photo Courtesy: MabPlex USA, Inc.

MabPlex Launches Two New Cell Culture Production Lines and Plans Further Expansion

MabPlex International, a fully integrated, Contract Development and Manufacturing Organization (CDMO) with sites in China (Yantai and Shanghai) and...

Five Prime Therapeutics Licenses Antibodies to Seattle Genetics

One day after Bristol-Myers Squibb and Five Prime Therapeutics announced that a randomized Phase II study testing the combination...

Loretta Itri, M.D., Joins Immunomedics as Chief Medical Officer

Biotech company Immunomedics today confirmed the appointment of Loretta Itri, M.D. as Chief Medical Officer (CMO). In her new...

OSE Immunotherapeutics and MAbSilico to Use AI in ADC Development

OSE Immunotherapeutics,  a clinical-stage biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology...

LakePharma and NJ Bio to Provide Streamlined Antibody-Drug Conjugate Services

Defying the traditional division between Contract Research Organizations (CRO) and contract development and manufacturing (CDMO), LakePharma has become the...

Syndivia In-Licenses SATT Conectus’ DARx Technology

France-based research-driven biotechnology company Syndivia receives the exclusive license from SATT Conectus to DARx technology. The novel technology allows...

European Regulators Approve Polatuzumab Vedotin, Triggering Milestone Payment for Seattle Genetics

The European Commission's conditional marketing authorization of polatuzumab vedotin (Polivy®; Genentech/Roche) earlier this week triggered a milestone payment which...